SCENESSE® approved for EPP in Canada

MELBOURNE, Australia, July 13, 2026 (GLOBE NEWSWIRE) — CLINUVEL’s novel drug SCENESSE® (afamelanotide) has been granted a Notice of Compliance (NOC) by Health Canada for the prevention of phototoxicity in